What is the recommended dosage and frequency of prednisone (corticosteroid) for treating Bell's palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Dosing for Bell's Palsy

For adults and adolescents 16 years and older with Bell's palsy, prescribe prednisone 60 mg once daily for 5 days, followed by a 5-day taper, initiated within 72 hours of symptom onset. 1, 2

Specific Dosing Regimens

You have two evidence-based options:

  • Option 1 (Preferred): Prednisone 60 mg once daily for 5 days, then taper over 5 days 1, 2
  • Option 2 (Alternative): Prednisolone 50 mg once daily for 10 days (no taper) 1, 2

Both regimens achieve excellent recovery rates: 83% at 3 months versus 63.6% with placebo, and 94.4% at 9 months versus 81.6% with placebo. 1, 2, 3

Critical Timing Window

  • Initiate treatment within 72 hours of symptom onset - this is the window where corticosteroids provide maximum benefit 1, 2
  • Treatment beyond 72 hours has unclear benefit and is not recommended 1, 2
  • The 72-hour window exists because early corticosteroid treatment reduces facial nerve inflammation before permanent damage occurs 4

Administration Details

  • Give as a single daily dose, not divided doses, to optimize therapeutic effect 4
  • Maximum dose should not exceed 60 mg daily 4
  • Administer in the morning to minimize sleep disturbance 2

Sample Taper Schedule (for 60 mg regimen)

  • Days 1-5: Prednisone 60 mg once daily 1, 2
  • Days 6-7: Prednisone 40 mg once daily 1
  • Days 8-9: Prednisone 20 mg once daily 1
  • Days 10: Prednisone 10 mg once daily 1

Critical Pitfall to Avoid

Never use methylprednisolone dose packs - they provide only 84 mg total over 6 days, which is grossly inadequate compared to 540 mg prednisone over 14 days for a 60-kg adult. 4 This is a common error that significantly undermines treatment efficacy.

Antiviral Therapy Considerations

  • Do NOT prescribe antiviral monotherapy - it is ineffective and not recommended 1, 2, 3
  • You may offer combination therapy (oral corticosteroid + antiviral) within 72 hours as an option, though the additional benefit is small 2, 5
  • If adding an antiviral: valacyclovir 1 g three times daily for 7 days OR acyclovir 400 mg five times daily for 10 days 5

Essential Concurrent Management

Implement aggressive eye protection immediately for any patient with impaired eye closure: 2, 4

  • Lubricating ophthalmic drops every 1-2 hours while awake 2
  • Ophthalmic ointment at bedtime 2
  • Eye taping or patching at night (with careful instruction to avoid corneal abrasion) 2
  • Sunglasses outdoors 2
  • Urgent ophthalmology referral if severe impairment or complete inability to close the eye 2, 6

Special Populations

Children: Evidence for steroid benefit in children is inconclusive, as children have higher spontaneous recovery rates (up to 90%) than adults. 1, 2, 5 If treating, consider prednisolone 1 mg/kg/day (maximum 50-60 mg) for 5 days followed by a 5-day taper, with substantial caregiver involvement in decision-making. 2

Pregnant women: Treat with oral corticosteroids within 72 hours using the same regimen, with individualized assessment of benefits and risks. 2

Follow-Up Requirements

  • Mandatory reassessment or specialist referral at 3 months if incomplete recovery 2, 6
  • Refer immediately for new or worsening neurologic findings at any point 2
  • Refer immediately for development of ocular symptoms 2
  • Most patients begin showing recovery within 2-3 weeks, with complete recovery typically within 3-4 months 2, 6

Expected Outcomes

  • Patients with incomplete paralysis: up to 94% recovery 2
  • Patients with complete paralysis: approximately 70% complete recovery within 6 months 2
  • Approximately 30% may experience permanent facial weakness with contractures 2, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early treatment with prednisolone or acyclovir in Bell's palsy.

The New England journal of medicine, 2007

Guideline

Corticosteroid Treatment for Iatrogenic Facial Nerve Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Guideline

Management of Iatrogenic Facial Nerve Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.